ASGCT
Join Catalent at ASGCT’s 27th Annual Meeting, taking place in the vibrant city of Baltimore from May 7-11! Connect with us to explore our comprehensive solutions for cell & gene therapies, covering raw materials to commercial manufacturing. Discover Catalent’s UpTempo℠ CAR-T and UpTempo℠ AAV Platforms which provide clients with a standardized and optimized workflow process to fast-track the path to patients.
Date: May 7-11, 2024
Location: Baltimore, Maryland
Booth: 415
JOIN US!
Complete the form to schedule a meeting with Catalent at ASGCT 2024.
SYMPOSIA PRESENTATION
Title: Accelerate Your AAV: Catalent’s UpTempo Platform Delivers Quality, Yield, and Speed
Speaker: Carey Connelly, Ph.D.
Date: May 9, 2024
Time: 2:30 – 5:00pm
Room: 337-338
TOOLS AND TECHNOLOGY FORUM
Title: Development of UpTempo CAR-T Platform and iPSC Platform to Speed Your Path to Patient for Your Autologous and Allogeneic Cell Therapies
Speaker: JunXia Wang, Ph.D.
Date: May 9, 2024
Time: 3:45 – 4:00pm
Room: Exhibit Hall Theater
SPEAKERS
Carey Connelly, Ph.D.
Senior Director, Product Development
Catalent Gene Therapy
JunXia Wang, Ph.D.
Senior Director, Product Development
Catalent Cell Therapy
ABOUT CATALENT CELL & GENE THERAPY
Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. Its comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. With deep expertise in viral vector development, scale-up and manufacturing for gene therapies and viral vectors, Catalent is a full-service partner for plasmid DNA, adeno-associated viral (AAV), lentiviral and other viral vectors, and oncolytic viruses. An experienced and innovative partner, Catalent Cell & Gene Therapy has a global network of dedicated development, clinical and commercial manufacturing facilities for small- and large-scale programs.
